Head-To-Head Analysis: Neogen

Head-To-Head Analysis: Neogen


Neogen and Quidel are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations. Neogen has higher revenue and earnings than Quidel.



from Biotech News